Look at more than 550 Drugs in Clinical Trial

DUBLIN, June 16, 2023 /PRNewswire/ — The “Global Cancer Antibody Drug Conjugates Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029” report has been added to  ResearchAndMarkets.com’s offering. Global Cancer Antibody Drug Conjugates Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029 Report Highlights: Global Antibody Drug Conjugates Market Opportunity: … Read more

Cano Health Announces Leadership Change to Advance Execution of Value Creation Plan

Mark Kent appointed Interim Chief Executive Officer Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and remain on the Board of Directors Launches search to identify permanent CEO and to refresh the Board with additional new independent directors MIAMI, June 16, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or … Read more

SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing

TORONTO, June 16, 2023 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF) today announced that the Company’s board of directors (the “Board“) has received a notice of intention (the “Notice“) to enforce security issued by its senior secured creditor, Pivot Financial I Limited Partnership (“Pivot“), under Section 244(1) of the Bankruptcy and … Read more

Healthcare Trust Announces Preferred Stock Dividends

NEW YORK, June 16, 2023 /PRNewswire/ — Healthcare Trust, Inc. (Nasdaq: HTIA / HTIBP) (“HTI”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, HTI declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) payable on July 17, … Read more

Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten Offering

WEXFORD, Pa., June 16, 2023 /PRNewswire/ — Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or the “Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced the closing of an underwritten offering for gross proceeds of approximately $3.5 million to a single healthcare focused investor prior to deducting underwriting discounts and commissions … Read more

China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HANGZHOU, China, June 16, 2023 /PRNewswire/ — China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company“), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on June 15, 2023, the Company has received a notification letter from Nasdaq Listing Qualifications … Read more

Evofem Biosciences Announces Financial Results for the First Quarter of 2023

— Increased net product revenue 37% in the first quarter of 2023 vs. prior year quarter — — Reduced operating expenses 72% — — Decreased loss from operations by 88% — — Reaffirms path to positive EBITDA — SAN DIEGO, June 16, 2023 /PRNewswire/ — Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced financial results for … Read more

Keches Law Files Class Action in Harvard Medical Morgue Scandal

Alleged illegal sale of human remains by former morgue manager caused emotional distress for families BOSTON, June 16, 2023 /PRNewswire/ — Keches Law Group filed a class action lawsuit Friday on behalf of families who suffered emotional distress due to the alleged illegal sale of human remains by the former morgue manager at Harvard Medical School. … Read more

The Inner Circle Acknowledges, James Oberman as a Top Pinnacle Professional for his contributions to the field of Otolaryngology and service in the US Navy

FREDERICK, Md., June 16, 2023 /PRNewswire/ — Prominently featured in The Inner Circle, James Oberman is acknowledged as a Top Pinnacle Professional for his contributions to the field of Otolaryngology and service in the US Navy. James Oberman Dr. Oberman pursued higher education at Boston College where he was an exceptional student earning the designation of … Read more

Texcell Unveils State-of-the-Art Viral Clearance Testing Facility

FREDERICK, Md., June 16, 2023 /PRNewswire/ — Texcell is pleased to announce the opening of their newest testing facility in North America, representing a significant milestone in Texcell’s commitment to advancing the viral safety of biotherapeutics and medical devices. Designed to support simultaneous viral clearance and biosafety studies, this 27,000 sq ft facility is built … Read more